Nongshim Lifill Derma Collagen Signature RN Won SIAL Innovation Selection

Nongshim’s health functional food brand Lifill announced that its flagship product, Derma Collagen Signature RN, won the SIAL Innovation Selection 2026 at the international food exhibition SIAL Paris, amnews.co.kr reported.

Global Recognition at SIAL Paris 2026

The SIAL Innovation program evaluates raw material new technologies, functional value, recipes, and packaging to recognize products that bring new value to the global food industry. Lifill’s Derma Collagen Signature RN earned selection through its proprietary skin health functional ingredient, Low Molecular Collagen Peptide NS, which was developed using Nongshim’s collagen research and development capabilities. According to nextdaily.co.kr, the ingredient utilizes a patented enzymatic hydrolysis process to lower the collagen molecular size to 173 Daltons, marking one of the lowest molecular sizes achieved in domestic production.

Human Trials Show Collagen Improves 31 Skin Indicators

Nongshim holds two patents for the ingredient and has secured three SCI-level papers detailing two human efficacy trials. Both amnews.co.kr and nextdaily.co.kr reported that human application tests across the Low Molecular Collagen Peptide NS ingredient demonstrated improvements in 31 skin health indicators, covering wrinkles, elasticity, moisture, and dead skin cells. The company noted that this represents the highest number of improved skin indicators recorded for a collagen product released domestically, with neck wrinkles and skin elasticity showing verifiable effects within 10 days. The product is marketed as "K-Collagen," distinguishing it from most imported collagen products by managing the entire process from raw material sourcing to final production within South Korea.

Nongshim Will Showcase Collagen Materials at SIAL Paris

Derma Collagen Signature RN is scheduled for display at the Nongshim exhibition booth during the SIAL Paris event starting October 17, 2026. Nongshim plans to use the exhibition space to introduce its self-developed collagen materials and research capabilities to international food industry professionals. A company representative stated that the selection validates the global innovativeness of Nongshim’s proprietary collagen material and related technologies, adding, We will continue to introduce innovative health functional foods that provide new value to consumers based on our differentiated R&D capabilities.

Unresolved International Market Expansion

While the company confirmed its intention to showcase the product to global buyers at the upcoming exhibition in France, neither amnews.co.kr nor nextdaily.co.kr detailed specific retail distribution partnerships, local regulatory approvals, or commercial sales timelines for international markets outside of domestic operations.